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ABSTRACT 27 
Pulse wave analysis (PWA) utilizes arm blood pressure (BP) waveforms to estimate aortic 28 
waveforms. The accuracy of central BP waveform estimation may be influenced by 29 
assessment site local hemodynamics. This study investigated whether local hemodynamic 30 
changes, induced via arm tilting +/-30° relative to heart level, affect estimated central 31 
systolic BP (cSBP) and arterial wave reflection (central augmentation index, cAIx; aortic 32 
backward pressure wave, Pb). In 20 healthy adults (26.7 y [SD 5.2], 10 F) brachial BP 33 
waveforms were simultaneously recorded on experimental and control arms. The 34 
experimental arm was randomly repositioned three times (heart level, -30° heart level, 35 
+30° heart level), while the control arm remained fixed at heart level. For the 36 
experimental arm, arm repositioning resulted in a large (partial eta-squared >0.14) effect 37 
size (ES) change in SBP (ES=0.75, P<0.001), cSBP (ES =0.81, P<0.001), and cAIx (ES =0.75, 38 
P=0.002), but not Pb (ES =0.06, P=0.38). In the control arm, cAIx (ES =0.22, P=0.013) but 39 
not SBP or cSBP significantly changed. Change in experimental arm cSBP was partially 40 
explained by brachial systolic blood velocity (P=0.026) and mean diameter (P=0.012), 41 
while change in cAIx was associated with brachial retrograde blood velocity (P=0.020) and 42 
beta stiffness (P=0.038). In conclusion, manipulation of assessment site local 43 
hemodynamics, including the blood velocity profile and local arterial stiffness, had a large 44 
effect on estimated cSBP and cAIx, but not Pb. These findings do not invalidate PWA 45 
devices but do suggest that the accuracy of the estimated aortic pressure waveform is 46 
dependent on stable peripheral hemodynamics. 47 
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INTRODUCTION 50 
Pulse wave analysis (PWA) devices permit the estimation of central hemodynamic 51 
properties, including arterial wave reflection (central augmentation index [cAIx], aortic 52 
backward pressure wave [Pb]), and central systolic blood pressure (cSBP). Considering that 53 
cSBP more closely reflects left ventricular and cerebrovascular load than brachial 54 
pressure,1,2 and is a more accurate marker of cardiovascular risk,2 PWA is increasingly 55 
attractive to epidemiologists and clinicians. However, the accuracy of central 56 
hemodynamic estimates may be influenced by local hemodynamic changes.  57 
 58 
Local pressure hemodynamics are influenced by gravitational changes, including small 59 
variation in the assessment site level relative to the heart. Such variation may occur with 60 
incorrect positioning of the arm, change in posture, or while using ambulatory devices. 61 
Pucci et al.3 examined the importance of gravitational changes by tilting the upper-limb 62 
30° above and 30° below heart level during supine PWA assessments. This experimental 63 
model is simple yet effective in that local hemodynamics are likely to be manipulated in 64 
the absence of central hemodynamic changes. Pucci et al.3 observed that peripherally 65 
derived indexes of cSBP and cAIx appeared ‘older’ when the upper arm was raised and 66 
‘younger’ when the upper arm was lowered. These changes occurred in the experimental 67 
arm despite no observable change in the fixed position (heart level) control arm, 68 
suggesting that ‘changes’ to the estimated central waveform were likely an artifact of local 69 
hemodynamic manipulation.  70 
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 71 
Unfortunately, Pucci et al. 3 did not measure important local hemodynamic properties, 72 
such as blood flow and local arterial stiffness. Further, cAIx but not Pb was measured. cAIx 73 
is known to be affected by the reflected wave transit time,4 whereas Pb is thought to be 74 
independent of the transit time5 and has been demonstrated to be more resistant to 75 
changes in posture.6–9 Therefore, the primary objective of this study was to investigate the 76 
effects of local hemodynamic manipulation, induced by tilting the arm +/-30 degrees 77 
relative to heart level, on PWA estimated cSBP, cAIx and Pb. The secondary objective was 78 
to determine the association between change in estimated cSBP, cAIx and Pb and change 79 
in local hemodynamic properties (arterial stiffness, blood velocity/flow).  80 
 81 
METHODS 82 
This study is reported in accordance with STROBE (Strengthening the Reporting of 83 
Observational Studies in Epidemiology) guidelines.10  84 
 85 
PARTICIPANTS 86 
Twenty young (18 – 40 y), healthy women (n=10) and men were recruited from a large 87 
state university. A healthy population sample was recruited to mitigate the risk of age- or 88 
disease-related influences on BP. Participants were excluded if they reported any known 89 
cardio-metabolic disorders, were taking medications known to affect cardiovascular 90 
function, or reported cigarette smoking. Ethical approval was obtained from the University 91 
Central hemodynamic estimation 
7 
This is an accepted manuscript of an article published by Springer Nature in Journal of 
Human Hypertension, available online at https://www.nature.com/articles/s41371-019-
0179-x. It is not the copy of record. Copyright © 2019, Springer Nature. 
of North Carolina at Chapel Hill institutional review board, and all participants provided 92 
written informed consent prior to participating in the study. 93 
 94 
EXPERIMENTAL DESIGN 95 
Participants were familiarized with all experimental procedures. Subsequently, all 96 
measures were collected on a single occasion in a quiet, dimly lit and environmentally 97 
controlled room between 7am and 10am. Participants fasted for 12h, consuming only 98 
water, and refraining from supplement intake that morning. Participants also avoided 99 
strenuous physical activity and alcohol for 24 h prior to experimentation. Prior to 100 
measurement commencement, participants rested quietly in the supine position for 20-101 
min, with both arms at heart level and stretched at a right angle.11 The experimental arm 102 
was supported on a table with an adjustable height and tilting surface, and the control 103 
arm was fixed at heart level.  104 
 105 
The experimental timeline is depicted in Figure 1. For each participant, measurements 106 
were made with the experimental arm in three positions: heart level (0°), -30° heart level, 107 
and +30° heart level, separated by 5 min rest prior to measurements. Re-positioning to +/- 108 
30°heart level was randomized, using two sets of 10 unique numbers generated from a 109 
number range of 1-20 (www.randomizer.org). At each experimental arm position PWA 110 
assessments were simultaneously made on both arms. A control arm was used to 111 
determine whether any changes in the estimated central BP waveform were real or an 112 
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artifact of local hemodynamic manipulation. Experimental arm local hemodynamic 113 
changes were measured using Duplex Doppler ultrasound. Lastly, to confirm central 114 
hemodynamic stability, continuous wave ultrasound was used to obtain trans-aortic 115 
Doppler flow profiles. All measurements were made in triplicate, with one min rest 116 
between readings, and the closest two recordings were averaged. 117 
 118 
PULSE WAVE ANALYSIS: EXPERIMENTAL ARM 119 
Oscillometric pressure waveforms were recorded by a single operator using a SphygmoCor 120 
XCEL device (AtCor Medical, Sydney, Australia). An appropriately sized cuff was selected 121 
according to manufacturer guidelines (small adult 17–25 cm, adult 23–33 cm, large adult 122 
31–40 cm) and placed around the left upper arm. Each measurement cycle lasted ~60 s. 123 
The upper arm cuff was initially inflated to measure brachial systolic (SBP) and diastolic 124 
(DBP) blood pressure, and then reinflated 5 s later to 10 mmHg below DBP to acquire a 125 
volumetric displacement signal for 10 s.12 The brachial waveforms were calibrated using 126 
the cuff-measured SBP and DBP, and mean arterial pressure (MAP) was derived by 127 
integrating the area under the curve.  A corresponding aortic pressure waveform was 128 
generated using a validated proprietary transfer function and calibrated using DBP and 129 
MAP.12 The aortic waveform was used to derive central: cSBP, diastolic BP (cDBP), pulse 130 
pressure (cPP), pulse pressure amplitude (PPamp), augmentation pressure (cAP), cAIx, 131 
cAIx normalized to a heart rate of 75 bpm (cAIx@75), aortic backward pressure wave (Pb), 132 
aortic forward pressure wave (Pf), and reflection magnitude (RM).  133 
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 134 
The PPamp is the ratio of peripheral pulse pressure to cPP multiplied by 100. The cAIx is 135 
defined as the cAP expressed as a percentage of cPP, where cAP is defined as the 136 
maximum cSBP minus the pressure at the inflection point. The Pf and Pb wave pressures 137 
were determined by assuming a triangular flow wave.13 This method creates a triangular-138 
shaped flow wave by matching the start, peak, and end of the flow wave to the timings of 139 
the foot, inflection point, and incisura of the aortic pressure wave. The RM was calculated 140 
as Pb/Pf.  141 
 142 
PULSE WAVE ANALYSIS: CONTROL ARM 143 
Oscillometric pressure waveforms were recorded on the upper arm using an Oscar 2 144 
(SunTech Medical, Morrisville, USA) and a cuff identical in size to the one used for the 145 
XCEL device. The Oscar 2 incorporates the same patented BP model as the XCEL, and has 146 
been validated according to the British Hypertension Society and the European Society of 147 
Hypertension International Protocol.14,15 Measurements included cSBP, cDBP, cPP, PPamp, 148 
cAP, cAIx, and cAIx@75. The Oscar 2 does not currently measure Pb, Pf or RM. 149 
 150 
DUPLEX DOPPLER ULTRASOUND: EXPERIMENTAL ARM 151 
A 11-2 mHz linear array probe (LOGIQ P6, GE Healthcare, Wauwatosa, USA) was used to 152 
record brachial artery brightness-mode images and pulsed doppler waveforms.16,17 The 153 
ultrasound probe was placed on the brachial artery, 5-10 cm proximal to the antecubital 154 
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fossa. The isonation angle was kept constant between 45° and 60° and the sample volume 155 
included most of the vessel. Three 10 s video recordings were taken at 30 Hz using an 156 
external video capture system (AV.io HD Frame Grabber, Epiphan Video, CA), during which 157 
the participant was asked to hold their breath without prior inhalation.  158 
 159 
The captured videos were analysed offline using specialized image analysis software (FMD 160 
Studio®, QUIPU, Italy), which outsourced (30 Hz) brachial artery diameters as well as 161 
antegrade and retrograde blood velocities. Blood velocities were analysed by tracing the 162 
peak envelope of the spectral waveform. Subsequently, custom-written Visual Basic code 163 
was used to fit peaks and troughs to the diameter waveforms to calculate diastolic (Dd), 164 
systolic (Ds), mean diameters (Dmean), and distention (Dist.).18,19 The Visual Basic software 165 
also automated the calculation of study outcomes: mean blood velocity (Vmean), diastolic 166 
blood velocity (Vdia), systolic blood velocity (Vsys), retrograde blood velocity (Vneg), mean 167 
blood flow (BFmean), change in blood flow over the cardiac cycle (∆BF), shear rate, 168 
oscillatory index (OI), conductance, and local arterial stiffness (beta-stiffness index [β]). 169 
Shear rate (s−1) was calculated as 4*mean velocity/diameter, blood flow as mean vessel 170 
area*mean blood velocity*60, conductance (ml·min·mmHg) as mean blood flow/MAP, 171 
and OI as retrograde shear rate / (antegrade shear rate + retrograde shear)*100.20 The 172 
values for OI range from 0 to 50, where zero is strictly antegrade shear and 50 is purely 173 
oscillatory. The ß was calculated as ln(SBP/DBP)/[(Ds-Dd)/Dd].  174 
 175 
Central hemodynamic estimation 
11 
This is an accepted manuscript of an article published by Springer Nature in Journal of 
Human Hypertension, available online at https://www.nature.com/articles/s41371-019-
0179-x. It is not the copy of record. Copyright © 2019, Springer Nature. 
CONTINUOUS-WAVE ULTRASOUND: TRANS-AORTIC 176 
Stroke volume (SV), cardiac output (CO) and systemic vascular resistance (SVR) were 177 
measured at each arm position using continuous-wave Doppler ultrasound (USCOM 1A, 178 
Uscom, Sydney, Australia). A single operator placed a 3.3MHz continuous-wave probe 179 
over the acoustic window at the level of the sternal notch to obtain trans-aortic Doppler 180 
flow profiles. Three 12 s recordings were taken for each arm position and the closest two 181 
were averaged. The BPs from the control arm were used to calculate SVR. 182 
 183 
SAMPLE SIZE  184 
Sample size calculations were based on cAIx, which has lower between-day reliability than 185 
the primary outcome, cSBP,6 and is similarly reliable to Pb.7 The mean change in derived 186 
cAIx reported following upper-limb tilt (+300 or -300) from heart level is approximately 187 
10% (data estimated from pooled data), but the smallest change reported is 188 
approximately 5%.3 The typical error of cAIx measurement using the SpygmoCor XCEL is 189 
5.2% for uncontrolled conditions.6 Using a conservative typical change during arm tilt of 190 
5% and a conservative typical error of 5.2%, with the maximum chances of a Type I error 191 
set at 5%, and a Type II error of 20%,we estimated the approximate number of 192 
participants required at 19.21 To permit even distribution by sex, the sample size was 193 
inflated to 20.   194 
 195 
STATISTICS 196 
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Statistical analyses were performed using Statistical Package for Social Sciences version 25 197 
(SPSS, Inc., Chicago, Illinois) and Hierarchical Linear Modelling-6 (Scientific Software 198 
International, Inc., Lincolnwood, Illinois). Statistical significance was defined as p<0.05 199 
(two tailed). To test for the main effect of arm position on each outcome analysis of 200 
variance (ANOVA) for repeated measurement was used, after verification of the normality 201 
of distributions. Homogeneity of variance was evaluated using Mauchly’s test of sphericity 202 
and, when violated, the Greenhouse-Geisser adjustment was used. In the event of a 203 
significant main effect, pairwise comparisons against heart level measurements were 204 
conducted. Effect sizes (ES) are reported using partial eta-squared (η2p), where 0.01, 0.06, 205 
and 0.14 represent a small, medium, and large effect, respectively.22  206 
 207 
Hierarchical Linear Modelling (HLM) was used to address the final objective, i.e., 208 
associations between change in estimated cSBP and arterial wave reflection and change in 209 
local artery hemodynamics. Three models were run for each analysis. Model 1 specified 210 
arm tilting (arm position relative to heart level), and was used to estimate measurement 211 
reliability.23 Model 2 specified the predictor which most strongly associated with outcome, 212 
as a group-centered to determine whether change in this variable helps to explain within-213 
subject variation for change in the outcome. Model 3 specified the next strongest 214 
predictor variable as a group-centered covariate.  215 
 216 
RESULTS 217 
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Local and central hemodynamic data for the experimental arm were successfully collected 218 
from all 20 participants (26.7 y [SD 5.2], 50% women, BMI 24.0 kg/m2 [SD 2.8]). For the 219 
control arm, PWA measurements were unsuccessful for one participant for an unknown 220 
reason. Additionally, ultrasound measures were unsuccessful on one participant due to 221 
poor video quality. These two participants were similar to the remainder of the population 222 
in terms of demographics and baseline hemodynamic measures.  223 
 224 
EXPERIMENTAL ARM MEASUREMENTS 225 
Pulse Wave Analysis 226 
All measurements are reported in Table 1. We observed no significant main effects of arm 227 
tilting on HR, PPamp, Pb, Pf or RM. However, there were large (ES=0.27-0.82), significant 228 
main effects of arm tilting on MAP, DBP, SBP, cSBP, cAP, cAIx, and cAIx75. Pairwise 229 
contrasts indicate that maneuvering the arm 30° above heart level resulted in significantly 230 
decreased MAP, DBP, SBP, cSBP, but non-significant changes in cAP, cAIx, and cAIx75. 231 
Conversely, positioning the arm 30° below heart level led to significantly increased MAP, 232 
DBP, SBP, cSBP, significantly decreased cAP and cAIx, and resulted in a non-significant 233 
decrease in cAIx75.  234 
 235 
Ultrasound 236 
We observed non-significant main effects for Vmean, BFmean, conductance, and shear rate. 237 
However, there were large (ES=0.20-0.60), significant main effects for distension, β , Vdia, 238 
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Vsys, Vneg, ∆BF and OI. Pairwise contrasts indicate that maneuvering the arm 30° above 239 
heart level resulted in significantly increased Vdia ,OI and Vneg, and a non-significant change 240 
in β, Dist, Vsys, and ∆BF. Conversely, positioning the arm 30° below heart level led to 241 
significantly increased β, significantly decreased Vsys and ∆BF, and had a non-significant 242 
effect on distention, Vmean, and Vneg. 243 
 244 
CONTROL MEASUREMENTS: CONTROL ARM AND TRANS-AORTIC 245 
All measurements are reported in Table 2. When the experimental arm was repositioned, 246 
we observed no significant main effects for HR, SBP, cSBP, PPamp, or cAP. However, there 247 
were large (ES=0.19-0.32) and significant main effects for MAP, DBP, cAIx and cAIx75. 248 
Pairwise contrasts indicate that maneuvering the experimental arm 30° above heart level 249 
resulted in significantly increased MAP and DBP and significantly decreased cAIx and 250 
cAIx75 in the control arm.  Positioning the experimental arm 30° below heart level also led 251 
to significantly increased MAP and DBP in the control arm but had a non-significant effect 252 
on cAIx and cAIx75. 253 
 254 
We observed no significant main effects for CO, SV or HR. However, there was a large 255 
(ES=0.25) and significant main effect for SVR. Pairwise contrasts indicate that maneuvering 256 
arm 30° above heart level significantly increased SVR, whereas positioning the arm 30° 257 
below heart level had a non-significant effect on SVR. 258 
 259 
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ASSOCIATIONS BETWEEN CENTRAL AND LOCAL HEMODYNAMIC 260 
MEASURES  261 
Data from 19 participant, for a total of 57 data points were available for the HLM models. 262 
Only cSBP and cAIx were modelled as these outcomes were influenced by arm tilting, 263 
whereas Pb was not. The ultrasound-derived local hemodynamic measures, which 264 
significantly changed in response to arm tilting, were considered for HLM analysis. Initially, 265 
each local hemodynamic variable was independently associated with cSBP and cAIx, using 266 
HLM. The variables which were significantly associated with cSBP or cAIx were specified as 267 
subject-centered in order of strength of association. Vsys and Dmean, and Vneg and β were 268 
found to be significant independent predictors of cSBP and cAIx, respectively. The HLM 269 
models for cSBP are reported in Table 3.  Model 3 shows that, after controlling for Vsys and 270 
Vmean, each 10° elevation in arm position, beginning at -30°, resulted in a 2.05 mmHg 271 
decrease in cSBP. The HLM models for cAIx are reported in Table 4. After controlling for 272 
Vneg and β, each 10° elevation in arm position, beginning at -30°, resulted in a 0.16% 273 
increase in cAIx. 274 
 275 
DISCUSSION 276 
Non-invasive PWA devices have been demonstrated to provide reliable6–8 and valid24,25  277 
estimates of central hemodynamic properties, and the prognostic value of cSBP has been 278 
recognized by expert consensus.2,26,27 The current findings do not invalidate PWA devices 279 
but do suggest that the accuracy of the estimated aortic pressure waveform is dependent 280 
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on stable local hemodynamics at the assessment site. Local hemodynamic manipulation, 281 
induced through arm tilting, had a large effect on estimated cSBP and cAIx, but not Pb. We 282 
further add to the extant literature by observing a direct association of cSBP and cAIx with 283 
local hemodynamic factors. These findings provide mechanistic insight into the factors 284 
influencing the accuracy of PWA.  285 
 286 
STRENGTHS AND LIMITATIONS 287 
The strengths and limitations of this study need to be addressed to best contextualize the 288 
findings. A major strength is the simultaneous measurement of peripheral and central 289 
hemodynamic variables. Additionally, the homogenous group of young, healthy 290 
participant permitted measurement of sensitive changes in hemodynamic variables 291 
without the confounding influence of age or disease-status. However, there were some 292 
limitations.  While our sample population did permit optimal signal to noise, further study 293 
with older and clinical populations is required to better generalize the findings. For 294 
example, in older participant sarterial wave reflection has been demonstrated to be less 295 
sensitive to change with arm tilting,3 in hypertensive participants the relationship 296 
between BP and arterial stiffness may be different,28 and the effects of sex are unknown. 297 
Additionally, we did not control for vasomotor changes resulting from arm movement.29 298 
However, the arm was moved slowly and was fully supported at all times, we did allow a 299 
5-min rest interval, and measurements were taken in triplicate. Lastly, the current study 300 
utilized an oscillometric device (XCEL) to estimate the aortic pressure waveform from the 301 
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brachial artery, and SphygmoCor originally developed a proprietary transfer function for 302 
use with radial artery tonometry. However, a proprietary transfer function has been 303 
developed specifically for the XCEL,12 and central hemodynamic outcomes derived from 304 
the XCEL have been validated using both radial artery tonometry12,30,31 and high-fidelity 305 
invasive catheterization.24,25   306 
 307 
CENTRAL SYSTOLIC BLOOD PRESSURE 308 
The overall displacement in peripheral SBP in the experimental arm was 15 mmHg, which 309 
is comparable to the 20 mmHg displacement reported by Pucci et al.3 Of particular 310 
interest, the PP amplification (ratio of central to peripheral PP) did not change with arm 311 
tilting for either study, suggesting that local pressure wave transmission directly 312 
influences the estimated central waveform. The estimated central waveform was similarly 313 
affected in both studies despite Pucci et al3 recording the peripheral waveform at the 314 
radial artery with tonometry, and the current study estimating the peripheral waveform at 315 
the brachial artery with oscillometry. Further, the changes to local and estimated cSBP 316 
occurred despite no changes to SBP or cSBP estimated from the control arm.  Herein, we 317 
extend the findings of Pucci et al3 by reporting that change in cSBP was found to be 318 
associated with local hemodynamic changes, including brachial artery systolic blood 319 
velocity and mean diameter. 320 
 321 
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Brachial artery systolic blood velocity was particularly susceptible to the arm being 322 
lowered, whereas brachial artery mean diameter was most susceptible to raising the arm. 323 
When lowering the arm, systolic blood velocity decreased despite no change in mean 324 
velocity, indicating that the shape of the velocity profile was altered rather than the 325 
overall volume of blood velocity. The change in systolic blood velocity shape may have 326 
been indicative of decreased downstream resistance as a result of blood pooling.19,32 The 327 
decreased downstream resistance may have directly influenced cSBP; however, decreased 328 
peripheral resistance would be expected to decrease cSBP.33 Alternatively, the altered 329 
systolic blood velocity may indicate mismatched pulsatile-pressure-flow relations.33,34 In 330 
turn, mean diameter is an indicator of the tone of the vessel, and a major determinant of 331 
local BP.33 However, mean diameter also plays an important general role in the local 332 
hemodynamic environment, including arterial stiffness and the blood velocity profile, and 333 
change in this variable may be indicative of more general change to the local 334 
environment. This may explain why, despite being associated with change in cSBP, 335 
specifying mean diameter in the hierarchical linear model did not reduce the change in 336 
cSBP with arm tilting. 337 
 338 
ARTERIAL WAVE REFLECTION 339 
In line with our BP findings, cAIx in the experimental arm changed similarly to that of Pucci 340 
et al.3 cAIx increased when the arm was raised (albeit not significantly in the current 341 
study), and decreased when the arm was lowered. Contrary to Pucci et al,3  we found that 342 
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cAIx significantly decreased (-4.7%) in the contralateral arm, predominantly when the 343 
experimental arm was raised. We further extend the findings of Pucci et al 3 by reporting 344 
that (i) change in experimental arm cAIx was found to be associated with change in 345 
brachial artery retrograde blood velocity and brachial arterial stiffness, and (ii) Pb did not 346 
significantly change with arm tilting. 347 
 348 
Antegrade blood velocity was particularly susceptible to the arm being raised, whereas 349 
brachial arterial stiffness was specifically susceptible to the arm being lowered. Antegrade 350 
blood velocity may have directly influenced the shape of the local pressure waveform, or 351 
may have simply been the consequence of increased downstream vascular resistance.32 352 
Considering the changes in antegrade blood velocity were small, the later explanation is 353 
more likely. Interestingly, brachial arterial stiffness increased with arm lowering while the 354 
cAIx decreased, which is opposite to what was expected. As such, perhaps it is not 355 
surprising that while both antegrade blood velocity and brachial arterial stiffness did 356 
decrease the hierarchical linear modelling estimate for change in cAIx with arm tilting, the 357 
standard error for the estimate did not decrease and nor did the residual (within-subject) 358 
variance. This indicates that while antegrade blood velocity and brachial arterial stiffness 359 
are associated with cAIx, other factors do contribute to a change in cAIx. One explanation 360 
is that at least part of the cAIx change is not artificial, and that arm tilting does have a 361 
small systemic effect. Indeed, contrary to Pucci et al,3  we observed changes to cAIx in the 362 
contralateral arm, and these changes are supported by small but robust changes in 363 
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systemic vascular resistance. Pucci et al3 may not have observed changes to cAIx in the 364 
contralateral arm as a result of the wide age range of study subjects.  365 
 366 
In contrast to cAIx, Pb did not significantly change in response to arm tilting. This finding 367 
supports previous work from our group indicating that, when compared to Pb, cAIx is 368 
more prone to error with change in body posture.6–8  Two potential sources of error may 369 
have limited the estimation of arterial wave reflections using cAIx: (i) the reflected wave 370 
transit time, and (ii) the generalized transfer function used to generate the aortic pressure 371 
waveform. (i) The cAIx is affected by the reflected wave transit time, which is influenced 372 
by the reflected wave timing, amplitude, and ventricular function, and which are known to 373 
be influenced by a number of factors, including heart rate.4 However, heart rate was not 374 
significantly affected by arm tilting. Alternatively, (ii) the generalized transfer function may 375 
less truly reproduce the high-frequency components required for cAIx computation than it 376 
does the low-frequency pressure harmonics required for Pb and Pf computation.35  377 
 378 
IMPLICATIONS 379 
Central BP measurement prognostic value has been recognized by expert consensus, and 380 
is gaining traction as a clinical outcome.2,26,27  The traction is supported by the validation 381 
of diagnostic thresholds,36 and evidence demonstrating that monitoring central BP, as 382 
opposed to conventional peripheral BP, aided in the management of hypertension, 383 
leading to decreased medication use without adverse effects on left ventricular mass.37 384 
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However, as with peripheral BP measures, central BP and arterial wave reflection are 385 
currently measured in both supine and seated positions, with the arm resting at various 386 
heights.38 Findings from the current study, along with previous work from our group and 387 
others, 3,6–9   suggest that lack of procedural standardization may have meaningful 388 
implications for patient management.  389 
 390 
Our findings may have particular relevance to 24-h ambulatory central BP devices, as 391 
changes in body posture and arm position may confound the accuracy of readings. As 392 
such, it is recommended that participants are instructed to remain supine during key 393 
measurement periods. Additionally, the current findings do indicate that Pb may be a 394 
more robust measure of arterial wave reflection than cAIx. Two large prospective 395 
studies39,40 suggest that wave separation analysis may be superior to cAIx as a subclinical 396 
marker of cardiovascular disease – one reporting that Pb better predicts 15-year 397 
cardiovascular mortality than cAIx,39 the other that reflection magnitude (Pb/Pf) better 398 
predicts cardiovascular events than cAIx.40 Whether or not Pb is a superior ambulatory 399 
measure than cAIx warrants further attention. 400 
 401 
CONCLUSIONS 402 
This study investigated whether changes to the local hemodynamic environment, induced 403 
through arm tilting, affect estimated cSBP and indices of arterial wave reflection. Arm 404 
tilting had no effect on Pb. However, arm tilting did have a large effect on estimated cSBP 405 
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and cAIx in the experimental arm, but not in the control arm.  The changes in cSBP and 406 
cAIx were partially explained by changes in local hemodynamic factors. These findings do 407 
not invalidate PWA devices but do suggest that the accuracy of the estimated aortic 408 
pressure waveform is dependent on stable peripheral hemodynamics at the measurement 409 
site. 410 
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 522 
FIGURES 523 
Figure 1. Study design. The experimental arm was passively repositioned three times 524 
(heart level [0°], below heart level [-30°], below heart level [+30°]), while the control arm 525 
remained fixed at heart level. Following repositioning a 5 min rest preceded 526 
measurements. Measurements on the experimental arm included pulse wave analysis 527 
(PWA, XCEL) and duplex Doppler ultrasound (USDD). On the control arm PWA (Oscar 2) 528 
measures were taken at the same time as experimental arm PWA measures. Lastly, for 529 
each arm position a continuous wave ultrasound (USCW) probe was placed at the level of 530 
the sternal notch to obtain trans-aortic Doppler flow profiles. All measurements were 531 
made in triplicate. 532 
 533 
TABLES 534 
Table 1. Hemodynamic measures on the experimental arm (n=20) 535 
Abbreviations: ES, effect size (partial eta squared), where 0.01, 0.06, and 0.14 represent a small, medium, 536 
and large effect, respectively; Cont., contrast; LCI, lower confidence interval (95%); UCI, upper confidence 537 
interval (95%);  538 
∆BF, change in blood flow (systole – diastole); cAIx, central augmentation index; cAIx75, cAIx normalize to a 539 
heart rate of 75 bpm; cAP, central augmentation pressure;  β, beta index stiffness; BFmean, mean blood flow; 540 
Cond., conductance; cSBP, central systolic blood pressure; DBP, diastolic blood pressure; Dist, distention 541 
(brachial diameter change); Dmean, mean arterial (brachial) diameter; MAP, mean arterial blood pressure; Pf, 542 
aortic forward pressure wave; Pb, aortic backward pressure wave; PPamp, pulse pressure amplitude; OI, 543 
oscillatory index; RM, reflection magnitude; SBP, systolic blood pressure; shear, shear rate; Vdia, diastolic 544 
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blood velocity; Vmean, mean blood velocity; Vneg, negative (retrograde) blood velocity; Vsys, systolic blood 545 
velocity 546 
 547 
 548 
Table 2. Control measurements: contralateral arm hemodynamic measures and central 549 
output (n=19) 550 
Abbreviations: cAIx, central augmentation index, AIx75, cAIx normalize to a heart rate of 75 bpm; cAP, 551 
central augmentation pressure; CO, cardiac output; cSBP, central systolic blood pressure; DBP, diastolic 552 
blood pressure; Dmean, mean arterial (brachial) diameter; HR, heart rate;  PPamp, pulse pressure amplitude; 553 
MAP, mean arterial blood pressure; SBP, systolic blood pressure; SV, stroke volume; SVR, systemic vascular 554 
resistance 555 
 556 
Table 3. Hierarchical linear modeling estimates for change in central systolic blood 557 
pressure (cSBP) with arm tilting (n=57 data points) 558 
Note: the slopes are reported as a 10°, rather than 1° or 30° change to aid interpretation. Measurements we 559 
only conducted at -30°, 0° and 30°. 560 
Abbreviations: Dmean, brachial artery mean diameter; Vsys, systolic blood velocity; 561 
 562 
Table 4. Hierarchical linear modeling estimates for change in central augmentation index 563 
(cAIx) with arm tilting (n=20) 564 
Note: the slopes are reported as a 10°, rather than 1° or 30° change to aid interpretation. Measurements we 565 
only conducted at -30°, 0° and 30°. 566 
Abbreviations: β, beta stiffness in the brachial artery; Vneg, negative (retrograde), blood velocity 567 
Central hemodynamic estimation 
28 
This is an accepted manuscript of an article published by Springer Nature in Journal of 
Human Hypertension, available online at https://www.nature.com/articles/s41371-019-
0179-x. It is not the copy of record. Copyright © 2019, Springer Nature. 
 568 
Central hemodynamic estimation 
29 
This is an accepted manuscript of an article published by Springer Nature in Journal of Human Hypertension, available online at 
https://www.nature.com/articles/s41371-019-0179-x. It is not the copy of record. Copyright © 2019, Springer Nature. 
Table 1. Hemodynamic measures on the experimental arm (n=57 data points) 569 
  30◦Above    Heart Level   30◦ Below    Significance 
 
30◦ Above Heart 
 
30◦ Below Heart 
  X SD   X SD   X SD   P ES   Cont. LCI UCI P   Cont. LCI UCI P 
MAP (mmHg) 77.3 5.6   82.2 5.4   91.9 6.0   <0.001 0.82   -4.64 -7.6 -1.7 0.002   9.76 12 7.2 0.000 
DBP (mmHg) 61.5 6.4   66.1 5.9   74.9 6.5   <0.001 0.80   -4.70 -7.5 -1.8 0.001   -13.3 -17 -9.9 0.000 
SBP (mmHg) 110 5.3   114 6.3   125 7.7   <0.001 0.75   -4.38 -7.5 -1.3 0.005   10.4 14 6.5 0.000 
cSBP (mmHg) 94.5 5.7   99.5 5.7   109 6.9   <0.001 0.81   -4.90 -7.8 -2.0 0.001   9.45 12 6.4 0.000 
PPamp (ratio) 1.46 0.6   1.45 0.9   1.47 0.9   0.199 0.08   0.16 -0.1 0.4 0.430   0.27 -0.1 0.7 0.301 
cAP (mmHg) 0.68 2.4   0.48 3.3   -1.55 4.2   0.002 0.29   0.20 -1.2 1.6 1.000   -2.15 -4.2 -0.2 0.033 
cAIx (%) 1.55 8.8   1.45 9.4   -4.63 12   0.002 0.27   0.10 -3.6 3.8 1.000   -6.20 -12 -0.7 0.023 
cAIx75 (%) -8.05 10   -9.00 13   -15.1 15   0.005 0.27   0.56 -3.5 4.6 1.000   -6.22 -13 0.4 0.070 
Pb (mmHg) 11.1 2.0   11.1 1.4   11.5 1.9   0.338 0.06   0.00 -0.8 0.8 1.000   0.45 -0.4 1.3 0.528 
Pf (mmHg) 25.0 2.3   24.8 2.6   25.3 3.5   0.809 0.01   0.20 -1.5 1.9 1.000   0.50 -1.6 2.6 1.000 
RM (%) 43.4 6.1   45.1 6.6   43.9 4.7   0.352 0.05   1.75 -5.9 2.4 0.840   -1.25 -4.6 2.1 1.000 
HR (bpm) 52.2 8.5   52.5 9.3   51.6 7.9   0.651 0.02   0.30 -2.4 1.8 1.000   -0.88 -3.3 1.5 1.000 
Dmean (mm) 3.68 0.7   3.58 0.8   3.61 0.8   0.075 0.26   0.11 0.0 0.2 0.105   0.01 -0.1 0.1 1.000 
Dist (mm) 0.08 0.0   0.07 0.0   0.05 0.0   0.002 0.29   0.01 0.0 0.0 0.537   -0.02 0.0 0.0 0.085 
β 29.3 9.2   28.5 8.0   39.0 13   0.002 0.30   0.77 -6.0 7.5 1.000   10.5 3.3 18 0.004 
Vdia (cm/s) 1.21 1.4   0.00 0.0   0.00 0.0   <0.001 0.44   1.21 0.4 2.1 0.005   na       
Vsys (cm/s) 84.8 15   81.7 16   62.9 14   <0.001 0.72   3.10 -2.9 9.1 0.564   -18.8 -26 -12 0.000 
Vmean (cm/s) 10.0 2.5   11.1 2.8   10.9 14   0.893 0.01   -1.08 -2.3 0.2 0.111   -0.16 -7.8 7.5 1.000 
Vneg (cm/s) -3.41 2.6   -1.96 1.4   -1.80 1.4   0.000 0.36   -1.45 -2.6 -0.3 0.011   0.16 -0.5 0.8 1.000 
BFmean (ml/min) 62.3 27   63.9 23   57.5 48   0.801 0.01   -1.55 -10 7.3 1.000   -6.33 -37 24 1.000 
∆BF (ml/min) 546 213   510 225   386 154   <0.001 0.60   -36.3 -19 92 0.300   -123 -187 -60.1 0.000 
Cond. (ml/min/mmHg) 0.81 0   0.78 0.3   0.63 0.6   0.275 0.07   0.03 -0.1 0.1 1.000   -0.16 -0.5 0.2 0.837 
Shear (s-1) 117 45   131 52   138 198   0.833 0.01   -20.2 -26 -1.7 0.022   6.42 -100 113 1.000 
OI (ratio) 23.8 12   14.3 6.5   15.5 9.5   0.001 0.33   9.47 2.8 16 0.005   1.20 -3.8 6.2 1.000 
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 574 
 575 
 576 
Table 2. Control measurements: contralateral arm hemodynamic measures and central output (n=19) 577 
  30◦ Above    Heart Level   30◦ Below    Significance   30◦ Above Heart   30◦ Below Heart 
  X SD   X SD   X SD   P ES   Cont. LCI UCI P   Cont. LCI UCI P 
MAP (mmHg) 82.1 6.8   79.9 5.8   81.9 6.3   0.002 0.32   2.26 0.6 3.9 0.006   1.9 0.5 3.4 0.007 
DBP (mmHg) 64.6 5.6   62.2 5.9   64.7 6.2   0.002 0.30   2.30 0.8 3.9 0.003   2.5 0.4 4.6 0.020 
SBP (mmHg) 117 9.7   115 8.6   117 8.6   0.166 0.10   1.50 -0.9 3.8 0.345   1.4 -0.3 3.2 0.139 
cSBP (mmHg) 103 9.3   102 7.4   103 8.2   0.164 0.11   1.26 -1.0 3.6 0.493   -1.2 -0.7 3.0 0.360 
PPamp (ratio) 1.39 0.8   1.37 0.7   1.38 0.8   0.270 0.07   0.19 -0.0 0.5 0.274   0.0 -0.1 -0.3 0.955 
cAP (mmHg) 1.42 5.3   2.84 4.9   1.79 4.1   0.068 0.14   -1.37 -3.1 323 0.140   -1.1 -2.6 0.5 0.258 
cAIx (%) 2.53 15   7.21 12   3.26 11   0.013 0.22   -4.74 -9.3 -0.2 0.041   -3.9 -7.9 0.1 0.054 
cAIx75 (%) -8.11 17   -3.00 15   -6.55 13   0.021 0.19   -5.21 -10.2 -0.2 0.039   -3.7 -8.5 1.2 0.181 
HROsccar (bpm) 52.1 7.7   53.4 8.2   53.3 7.5   0.059 0.15   -1.47 -3.1 0.2 0.095   -0.2 -1.9 1.5 1.000 
HRUSCOM (bpm) 51.8 9.3   52.3 10   52.1 8.3   0.906 0.01   -0.43 -2.5 1.7 1.000   -0.2 -3.2 2.8 1.000 
CO (l/min) 4.30 1.3   4.46 1.3   4.41 0.9   0.344 0.06   -0.17 -0.4 0.0 0.044   -0.1 -0.4 0.3 1.000 
SV (mL) 83.1 20   85.3 19   85.6 19   0.171 0.09   -2.25 -5.8 1.3 0.335   0.2 -3.5 3.9 1.000 
SVR (d⋅sec⋅cm-5) 1653 425   1528 377   1569 331   0.004 0.25   125 47 202 0.001   41 -60 143 0.900 
Central hemodynamic estimation 
31 
This is an accepted manuscript of an article published by Springer Nature in Journal of Human Hypertension, available online at 
https://www.nature.com/articles/s41371-019-0179-x. It is not the copy of record. Copyright © 2019, Springer Nature. 
 578 
 579 
 580 
 581 
 582 
 583 
 584 
 585 
 586 
 587 
 588 
 589 
Table 3. Hierarchical linear modeling estimates for change in central systolic blood pressure (cSBP) with arm tilting (n=20) 590 
    Model 1   Model 2   Model 3   
    Est. SE P   Est. SE P   Est. SE P   
Fixed Effects                           
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Intercept (-30°) β00 103 1.3 <0.001   103 1.3 <0.001   103 1.3 <0.001 Initial cSBP, arm at -30° 
Arm Tilt (per 10°) β10 -2.39 0.2 <0.001   -1.82 0.3 <0.001   -2.05 0.3 <0.001 cSBP per 10° degree elevation 
Vsys β20         -0.02 0.1 0.008   -0.13 0.1 0.026 cSBP change per 1 unit Vsys 
Dmean                   8.1 4.1 0.012 cSBP change per 1 unit Dmean 
Random Variance                            
Intercept U00 5.33   <0.001   5.38   <0.001   5.40   <0.001 Between-subject variance 
Residual E 3.26       2.99   3.23   2.85     Within-subject variance 
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Table 4. Hierarchical linear modeling estimates for change in central augmentation index (AIx) with arm tilting (n=20) 607 
    Model 1   Model 2   Model 3   
    Est. SE P   Est. SE P   Est. SE P   
Fixed Effects                           
Intercept (-30°) β00 0.91 2.22 0.686   0.91 2.22 0.686   0.91 2.22 0.686 Initial cAIx, arm at -30° 
Arm Tilt (per 10°) β10 0.92 0.34 0.015   0.48 0.39 0.240   0.16 0.39 0.692 cAIx per 10° degree elevation 
Vneg           -1.66 0.70 0.029   -1.69 0.08 0.020 cAIx change per 1 unit Vneg 
 β                   -0.19 0.66 0.038 cAIx change per 1 unit β 
Random Variance                            
Intercept U00 9.25   <0.001   9.22   <0.001   9.25   <0.001 Between-subject variance 
Slope U10 0.97   0.030   0.93   0.059   0.74   0.298 Between-subject variance 
Residual E 4.87       5.04       4.93     Within-subject variance 
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